http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011132839-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 |
| filingDate | 2011-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2011132839-A |
| titleOfInvention | METHOD FOR DIAGNOSTIC AND TREATMENT OF DISORDERS OF FUNCTION OF SLEEP-PRODUCING SYSTEM IN THE EYE OF ISCHEMIC SYNDROME |
| abstract | A method for the diagnosis and treatment of dysfunction of the tear production system in ocular ischemic syndrome, including tear replacement therapy, characterized in that if there are changes relative to the rate of total tear production, blood flow in the lacrimal gland and conjunctiva microcirculation state, subcutaneously retroauricularly 2.0 ml of 2% lidocaine and 0 5 ml of 10% mildronate and with an increase in the total tear production by at least 2 mm, an increase in the maximum systolic blood flow velocity in the lacrimal gland by at least 3 cm / s, improving the condition of conjunctival microcirculation - reducing the conjunctival index by at least 5 points after 60 minutes, then determine the ocular ischemic syndrome in the form of ischemic lesions of the tear production organs and prescribe subcutaneous retroauricular administration of this mixture of drugs daily, on both sides, a course of 6-8 days. |
| priorityDate | 2011-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.